ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 789,67
1,44%
DAX
18 518,03
-0,44%
Brent Oil
83,285
-1,25%
Bitcoin
64 352,29
-0,77%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
04/09/201414h00Business WireTeva to Present at the Morgan Stanley Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
04/09/201414h00Business WireTeva Announces Launch of Generic Baraclude® Tablets, 0.5mg and 1mg, in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201415h57Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201414h00Business WireTeva Launches SYNCareTM Home Administration Support Program for Patients on SYNRIBO® (Omacetaxine Mepesuccinate) for InjectionNYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201414h00Business WireData to be Presented at MS Boston 2014: Joint ACTRIMS-ECTRIMS Meeting Underscore Teva’s Commitment to Developing Solutions ...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/09/201408h00Business WireTeva Announces UK High Court Gives Positive Judgment in the Company’s Patent Case Against AstraZenecaNYSE:TEVATeva Pharmaceutical Industries Ltd
02/09/201414h01Business WireTeva’s Reslizumab Delivers Clinically & Statistically Significant Reduction in Asthma Exacerbations in Two Pivotal Phase II...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/08/201422h20Dow Jones NewsU.S. Restricts Narcotic Pain Drug PrescriptionsNYSE:TEVATeva Pharmaceutical Industries Ltd.
21/08/201422h01PR Newswire (US)OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung CancerNYSE:TEVATeva Pharmaceutical Industries Ltd
21/08/201421h30Dow Jones NewsDEA Restricts Narcotic Pain Drug PrescriptionsNYSE:TEVATeva Pharmaceutical Industries Ltd.
08/08/201400h05Dow Jones NewsADR Shares End Lower; Statoil Shares Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201418h04Business WireTeva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) FormulationNYSE:TEVATeva Pharmaceutical Industries Ltd
07/08/201412h30PR Newswire (Canada)OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial OfficerNYSE:TEVATeva Pharmaceutical Industries Ltd
31/07/201415h49Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd.
31/07/201413h00Business WireTeva Reports Second Quarter 2014 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
30/07/201420h15Business WireAll Proposals Approved at Teva's Annual Meeting of ShareholdersNYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/201414h00Business WireTeva Completes Acquisition of Labrys: Opens Door to a Strong & Novel Migraine Prevention & Treatment Franchise within its CNS...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201414h00Business WireTeva to Report Second Quarter 2014 Financial Results on July 31, 2014NYSE:TEVATeva Pharmaceutical Industries Ltd
16/07/201414h46Business WireLeading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders’ Meeting ProposalsNYSE:TEVATeva Pharmaceutical Industries Ltd
14/07/201414h00Business WireTeva Announces FDA Acceptance of NDA Filing for Investigational Short-Acting Beta-Agonist (SABA) Inhaler (Albuterol MDPI)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/07/201423h30Dow Jones NewsADR Shares End Higher; America Movil, Teva Shares Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
09/07/201412h43Dow Jones NewsEU Fines Servier, Generic Drug-Makers EUR427.7 Million for Violating Antitrust RulesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/07/201408h00Business WireTeva Receives CHMP Positive Opinion for Seasonique® Extended-Regimen Contraceptive for Marketing Authorization in Several Eu...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/07/201414h39Business WireADDING MULTIMEDIA Teva Files Citizen Petition with the U.S. Food & Drug Administration (FDA) Regarding the Complexity of COPA...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/07/201414h00Business WireTeva Files Citizen Petition with the U.S. Food & Drug Administration (FDA) Regarding the Complexity of COPAXONE® (glatiramer...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/06/201414h59Business WireTeva Reaches Settlement in ProAir® HFA Patent CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201423h07Dow Jones NewsADR Shares End HigherNYSE:TEVATeva Pharmaceutical Industries Ltd.
17/06/201414h00Business WireTeva Reaches Settlements In NUVIGIL® Patent CaseNYSE:TEVATeva Pharmaceutical Industries Ltd
12/06/201422h57Dow Jones NewsAppeals Court Backs Teva Over Hepatitis Drug's PatentNYSE:TEVATeva Pharmaceutical Industries Ltd
12/06/201421h32Business WireTeva Announces U.S. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® PatentNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
EN
Bouygues
NYSE
NKE
Nike
EU
PX1
CAC 40
EU
HO
Thales
EU
SGO
Cie de SaintGobain
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
EU
PX4
SBF 120
NYSE
MRK
Merck
EU
VK
Vallourec
EU
ACA
Credit Agricole
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés